Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2

Conditions

Multiple Myeloma 14Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma 2Leukemia, Plasma Cell 2Triple Negative Breast Neoplasms 1Smoldering Multiple Myeloma 1Recurrence 1Paraproteinemias 1Neoplasms, Plasma Cell 1Neoplasms 1Immunoglobulin Light-chain Amyloidosis 1Hematologic Diseases 1Hemangioma, Cavernous, Central Nervous System 1Corneal Diseases 1Blood Protein Disorders 1

Interventions

daratumumab 2plerixafor 1pegylated granulocyte colony-stimulating factor 1ferric pyrophosphate 1dexamethasone acetate 1dexamethasone 21-phosphate 1carfilzomib 1auricularum 1Stem Cell Transplantation 1Specimen Handling 1Melphalan 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Hyaluronoglucosaminidase 1Fluorodeoxyglucose F18 1Dexamethasone 1Calcium Dobesilate 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Leukemia, Plasma Cell × daratumumab × Clear all
NCT07605416 2026-05-26

Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial

National Cancer Institute (NCI)

Phase 2 Not yet recruiting
74 enrolled
Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell

NCT05054478 2021-09-23

PCL-2

Assistance Publique - Hôpitaux de Paris

Phase 2 Not yet recruiting
29 enrolled
Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡